Press Releases

Year 2010 |Year 2009 | Year 2008 | Year 2007 | Year 2006 | Year 2005 | Year 2004

• Nov. 30, 2007
  Welichem Established Loan Facility with Major Shareholder More...
  
  
• Oct. 30, 2007
  Welichem Filed Quarterly Report for Period Ended August 31, 2007 More...
  
  
• Oct. 30, 2007
  Welichem announces results of annual and special general meeting More...
  
  
• Sept. 27, 2007
  Welichem Files its Annual Audited Financials for Year Ended May 31, 2007, and Announces its AGM/SGM Date More...
  
  
• Sept. 07, 2007
  Welichem Biotech Successfully Moves to Higher Dose for Phase I Clinical Trials More...
  
  
• Aug. 07, 2007
  Phase I Clinical Trial Underway for Welichem Biotech More...
  
  
• July. 16, 2007
  Welichem Appoints Business Development Manager More...
  
  
• July. 10, 2007
  Welichem Gets Approval for Phase I Clinical Trials More...
  
  
• Jun. 11, 2007
  Welichem Awarded Contribution from NRC-IRAP for Research on Novel Anticancer Compound More...
  
  
• Jun. 07, 2007
  Welichem Announces Closing Of Non-Brokered Private Placement More...
  
  
• Apr. 26, 2007
  Welichem Filed Quarterly Report for Period Ended February 28, 2007 More...
  
  
• Apr. 13, 2007
  Welichem Biotech to Report to Major Anti-Cancer Conference More...
  
  
• Mar. 28, 2007
  Welichem Announces Arrangement of Non-Brokered Private Placement More...
  
  
• Feb. 12, 2007
  Welichem Participated in BioPartnering North America Conference 2007 More...
  
  
• Feb. 01, 2007
  Welichem Announces Grant of Incentive Stock Options More...
  
  
• Jan. 30, 2007
  Welichem Filed Quarterly Report for Period Ended November 30, 2006 More...
  
  
• Jan. 29, 2007
  Welichem Biotech Inc. Appoints Investor Relations Officer More...
  
  
• Jan. 22, 2007
  Welichem’s Anti-cancer Drug Candidate Stimulates the Immune System More...